search
Back to results

Impact of Extent of Antral Resection on Outcomes of Sleeve Gastrectomy (LSG)

Primary Purpose

Obesity

Status
Completed
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
LSG started 2 cm from the pylorus
LSG started 6 cm from pylorus
Sponsored by
Mansoura University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Obesity focused on measuring Bariatric surgery, sleeve gastrectomy, gastric leak

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • patients, who were treated for morbid obesity by laparoscopic sleeve gastrectomy (LSG)

Exclusion Criteria:

  • patients above 60 or below 18 years old, history of upper laparotomy, unfit for anaesthesia or laparoscopy, major psychological instability, and drug abuse.

Sites / Locations

  • Ayman El Nakeeb

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

LSG started 2 cm from the pylorus

LSG started 6 cm from pylorus

Arm Description

laparoscopic sleeve gastrectomy starting 2 cm from the pylorus

LSG started 6 cm from pylorus

Outcomes

Primary Outcome Measures

percent of excess weight loss
The percent of EWL was calculated as follows: [(preoperative weight-follow up weight)/preoperative excess weight] ×100.

Secondary Outcome Measures

length of postoperative stay
length of postoperative stay
postoperative complications
gastric leakage, internal haemorrhage, pulmonary complications). Complications were graded according to their severity on a validated five point scale using Dindo-Clavien complication classification system) into (grades I, II, IIIa-b, IVa-b, V). Grade I (no need for specific intervention), grade II (need for drug therapy such antibiotics, blood transfusion, total parenteral nutrition), grade IIIa-b (need for invasive therapy radiological, endoscopic or surgical), grade IVa-b (organ dysfunction requiring ICU stay and management), grade V (death)
weight regain
an increase of body weight of more than 10 kg from the nadir
Resolution of comorbidity
Resolution of comorbidity was considered if the disease is controlled without any medications.

Full Information

First Posted
October 26, 2013
Last Updated
November 20, 2015
Sponsor
Mansoura University
search

1. Study Identification

Unique Protocol Identification Number
NCT01974388
Brief Title
Impact of Extent of Antral Resection on Outcomes of Sleeve Gastrectomy
Acronym
LSG
Official Title
Impact of Extent of Antral Resection on Surgical Outcomes of Sleeve Gastrectomy for Morbid Obesity (A Prospective Randomized Study)
Study Type
Interventional

2. Study Status

Record Verification Date
January 2008
Overall Recruitment Status
Completed
Study Start Date
January 2008 (undefined)
Primary Completion Date
January 2012 (Actual)
Study Completion Date
January 2012 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Mansoura University

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Laparoscopic sleeve gastrectomy (LSG) is a surgical technique that treats morbid obesity by both restrictive and hormonal action. Consecutive patients with morbid obesity treated by LSG at our department were evaluated. Patients enrolled in the study were randomized into Group I: LSG begin the division 2 cm from the pylorus and Group II: LSG begin the division 6 cm from the pylorus. The primary outcome measure was the % of excess weight loss (%EWL); secondary outcomes included operative time, day to resume oral feeding, postoperative morbidity and mortality, improvement of comorbidity.
Detailed Description
This prospective randomized study was designed to compare between the beginning of sleeve gastrectomy 2 cm versus 6 cm from the pylorus with special regards to intraoperative problems, weight loss, improvement of comorbidities, postoperative complications, nutritional and elemental deficiencies. Consecutive patients, who were treated for morbid obesity by laparoscopic sleeve gastrectomy (LSG) at the department of general surgery, Mansoura University, Egypt, during the period from January 2008 to January 2012, were eligible for the study. The exclusion criteria included patients above 60 or below 18 years old, history of upper laparotomy, unfit for anaesthesia or laparoscopy, major psychological instability, and drug abuse. The operation was done under general anesthesia. Patient was in supine position with splitting of the operating table legs.Gastric transection started 2 cm proximal to the pylorus using 60 mm, green endo-stapler (Ethicon, USA) (GI) or 6 cm from the pylorus (G II). The following staplers were placed approximately 1 cm from the bougie in the direction of the gastroesophageal junction. Group I: LSG begin the division 2 cm from the pylorus and Group II: LSG begin the division 6 cm from the pylorus. The primary outcome measure was the % of excess weight loss (%EWL); secondary outcomes included operative time, day to resume oral feeding, postoperative morbidity and mortality, improvement of comorbidity.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity
Keywords
Bariatric surgery, sleeve gastrectomy, gastric leak

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
105 (Actual)

8. Arms, Groups, and Interventions

Arm Title
LSG started 2 cm from the pylorus
Arm Type
Active Comparator
Arm Description
laparoscopic sleeve gastrectomy starting 2 cm from the pylorus
Arm Title
LSG started 6 cm from pylorus
Arm Type
Active Comparator
Arm Description
LSG started 6 cm from pylorus
Intervention Type
Procedure
Intervention Name(s)
LSG started 2 cm from the pylorus
Other Intervention Name(s)
Group I
Intervention Description
Laparoscopic sleeve gastrectomy started 2 cm from pylorus
Intervention Type
Procedure
Intervention Name(s)
LSG started 6 cm from pylorus
Other Intervention Name(s)
Group II
Intervention Description
LSG started 6 cm from pylorus
Primary Outcome Measure Information:
Title
percent of excess weight loss
Description
The percent of EWL was calculated as follows: [(preoperative weight-follow up weight)/preoperative excess weight] ×100.
Time Frame
one year postoperative
Secondary Outcome Measure Information:
Title
length of postoperative stay
Description
length of postoperative stay
Time Frame
30 days
Title
postoperative complications
Description
gastric leakage, internal haemorrhage, pulmonary complications). Complications were graded according to their severity on a validated five point scale using Dindo-Clavien complication classification system) into (grades I, II, IIIa-b, IVa-b, V). Grade I (no need for specific intervention), grade II (need for drug therapy such antibiotics, blood transfusion, total parenteral nutrition), grade IIIa-b (need for invasive therapy radiological, endoscopic or surgical), grade IVa-b (organ dysfunction requiring ICU stay and management), grade V (death)
Time Frame
one year postoperative
Title
weight regain
Description
an increase of body weight of more than 10 kg from the nadir
Time Frame
one year postoperative
Title
Resolution of comorbidity
Description
Resolution of comorbidity was considered if the disease is controlled without any medications.
Time Frame
one year postoperative

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: patients, who were treated for morbid obesity by laparoscopic sleeve gastrectomy (LSG) Exclusion Criteria: patients above 60 or below 18 years old, history of upper laparotomy, unfit for anaesthesia or laparoscopy, major psychological instability, and drug abuse.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ayman El Nakeeb, MD
Organizational Affiliation
Mansoura University
Official's Role
Study Director
Facility Information:
Facility Name
Ayman El Nakeeb
City
Mansoura
ZIP/Postal Code
35111
Country
Egypt

12. IPD Sharing Statement

Citations:
PubMed Identifier
21861236
Citation
Ferrer-Marquez M, Belda-Lozano R, Ferrer-Ayza M. Technical controversies in laparoscopic sleeve gastrectomy. Obes Surg. 2012 Jan;22(1):182-7. doi: 10.1007/s11695-011-0492-0.
Results Reference
result
PubMed Identifier
20730606
Citation
Pomerri F, Foletto M, Allegro G, Bernante P, Prevedello L, Muzzio PC. Laparoscopic sleeve gastrectomy--radiological assessment of fundus size and sleeve voiding. Obes Surg. 2011 Jul;21(7):858-63. doi: 10.1007/s11695-010-0255-3.
Results Reference
result
PubMed Identifier
20379795
Citation
Shi X, Karmali S, Sharma AM, Birch DW. A review of laparoscopic sleeve gastrectomy for morbid obesity. Obes Surg. 2010 Aug;20(8):1171-7. doi: 10.1007/s11695-010-0145-8.
Results Reference
result
PubMed Identifier
19572113
Citation
Sanchez-Santos R, Masdevall C, Baltasar A, Martinez-Blazquez C, Garcia Ruiz de Gordejuela A, Ponsi E, Sanchez-Pernaute A, Vesperinas G, Del Castillo D, Bombuy E, Duran-Escribano C, Ortega L, Ruiz de Adana JC, Baltar J, Maruri I, Garcia-Blazquez E, Torres A. Short- and mid-term outcomes of sleeve gastrectomy for morbid obesity: the experience of the Spanish National Registry. Obes Surg. 2009 Sep;19(9):1203-10. doi: 10.1007/s11695-009-9892-9. Epub 2009 Jul 2.
Results Reference
result
PubMed Identifier
24728866
Citation
Abdallah E, El Nakeeb A, Youssef T, Abdallah H, Ellatif MA, Lotfy A, Youssef M, Elganash A, Moatamed A, Morshed M, Farid M. Impact of extent of antral resection on surgical outcomes of sleeve gastrectomy for morbid obesity (a prospective randomized study). Obes Surg. 2014 Oct;24(10):1587-94. doi: 10.1007/s11695-014-1242-x. Erratum In: Obes Surg. 2015 Oct;25(10):1987. Yousef, Tamer [Corrected to Youssef, Tamer].
Results Reference
derived
Links:
URL
http://www.mans.edu.eg/
Description
Mansoura university, Mansoura, Egypt

Learn more about this trial

Impact of Extent of Antral Resection on Outcomes of Sleeve Gastrectomy

We'll reach out to this number within 24 hrs